Skip to main content
NIH funding notice RFA-TR-21-009

Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional)

Closed on June 10, 2021.

Posted
February 3, 2021
Close date
June 10, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
3
3 new
Median first-year cost
$988,302
$2,958,523 in all
Institutions
3
3 contact PIs
Patents
1
from 1 funded project

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. BRIGHAM AND WOMEN'S HOSPITAL1
  2. UNIVERSITY OF CALIFORNIA AT DAVIS1
  3. UNIVERSITY OF MICHIGAN AT ANN ARBOR1

Most frequent study sections

  1. Special Emphasis Panel (ZTR1 DPI-5 (01))3
3 awards under RFA-TR-21-009 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2022A Novel Device for Rapid and Noninvasive Volatile Metabolite-based Screening and Diagnosis of Multiple Disease States1U01TR004072-01Koo, SophiaBRIGHAM AND WOMEN'S HOSPITAL, MAFirst-year cost $1,024,145Study section ZTR1
FY2022Monitoring of disease-induced skin VOC patterns from handheld and wearable chemical sensors1U01TR004083-01Davis, Cristina ElizabethKenyon, Nicholas J.UNIVERSITY OF CALIFORNIA AT DAVIS, CAFirst-year cost $988,302Study section ZTR1
FY2022High performance wearable body odor sensor arrays for disease detection and monitoring1U01TR004066-01Fan, XudongGudjonsson, Johann EliGunnerson, Kyle JeromeHuang, Yvonne JeanMahajan, PrashantUNIVERSITY OF MICHIGAN AT ANN ARBOR, MIFirst-year cost $946,076Study section ZTR1
Newest fiscal year first, then first-year cost.

Patents from its funded projects

1 patent names 1 of the 3 funded projects.

  1. US 12,667,301 (opens the patent at USPTO, a PDF, in a new tab)Transepidermal Water Loss Measurement DeviceGranted June 30, 2026 to The Regents of The University of MichiganU01TR004066 · UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI

Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.

Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-TR-21-009: Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional) | ScienceDex | ConductScience